Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 486

1.
2.

Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.

Grosse J, Kramer G, Jakse G.

BJU Int. 2009 Sep;104(5):651-6. doi: 10.1111/j.1464-410X.2009.08466.x. Epub 2009 Mar 5.

3.

Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre.

Del Popolo G, Filocamo MT, Li Marzi V, Macchiarella A, Cecconi F, Lombardi G, Nicita G.

Eur Urol. 2008 May;53(5):1013-19. Epub 2007 Oct 1.

PMID:
17950989
5.
6.

Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity.

Reitz A, Denys P, Fermanian C, Schurch B, Comperat E, Chartier-Kastler E.

Eur Urol. 2007 Dec;52(6):1729-35. Epub 2007 Sep 4.

PMID:
17884281
7.

Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity.

Gamé X, Khan S, Panicker JN, Kalsi V, Dalton C, Elneil S, Hamid R, Dasgupta P, Fowler CJ.

BJU Int. 2011 Jun;107(11):1786-92. doi: 10.1111/j.1464-410X.2010.09791.x. Epub 2010 Oct 29.

8.

Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.

Schmid DM, Sauermann P, Werner M, Schuessler B, Blick N, Muentener M, Strebel RT, Perucchini D, Scheiner D, Schaer G, John H, Reitz A, Hauri D, Schurch B.

J Urol. 2006 Jul;176(1):177-85.

PMID:
16753396
9.

Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity.

Karsenty G, Reitz A, Lindemann G, Boy S, Schurch B.

Urology. 2006 Dec;68(6):1193-7. Epub 2006 Dec 4.

PMID:
17141831
10.

[Efficacy of repeat injections of botulinum A toxin to the detrusor in neurogenic bladder overactivity].

Chenet A, Perrouin-Verbe B, Le Normand L, Labat JJ, Brunel P, Lefort M, Mathé JF.

Ann Readapt Med Phys. 2007 Nov;50(8):651-60. Epub 2007 Apr 20. French.

PMID:
17490775
11.

Botulinum-a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder.

Schulte-Baukloh H, Michael T, Stürzebecher B, Knispel HH.

Eur Urol. 2003 Jul;44(1):139-43.

PMID:
12814690
12.

Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.

Giannantoni A, Mearini E, Del Zingaro M, Porena M.

Eur Urol. 2009 Mar;55(3):705-11. doi: 10.1016/j.eururo.2008.08.048. Epub 2008 Sep 2.

PMID:
18814955
13.
14.

Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.

Karsenty G, Denys P, Amarenco G, De Seze M, Gamé X, Haab F, Kerdraon J, Perrouin-Verbe B, Ruffion A, Saussine C, Soler JM, Schurch B, Chartier-Kastler E.

Eur Urol. 2008 Feb;53(2):275-87. Epub 2007 Oct 16. Review.

PMID:
17988791
15.

Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis.

Schulte-Baukloh H, Schobert J, Stolze T, Stürzebecher B, Weiss C, Knispel HH.

Neurourol Urodyn. 2006;25(2):110-5.

PMID:
16470519
16.

Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.

Akbar M, Abel R, Seyler TM, Bedke J, Haferkamp A, Gerner HJ, Möhring K.

BJU Int. 2007 Sep;100(3):639-45. Epub 2007 May 26. Erratum in: BJU Int. 2007 Sep;100(3):719. Bedke, Jens [added]; Haferkamp, Axel [added].

17.

Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity.

Sahai A, Dowson C, Khan MS, Dasgupta P; GKT Botulinum Study Group.

Urology. 2010 Mar;75(3):552-8. doi: 10.1016/j.urology.2009.05.097. Epub 2009 Dec 29.

PMID:
20035984
18.

Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.

Gamé X, Castel-Lacanal E, Bentaleb Y, Thiry-Escudié I, De Boissezon X, Malavaud B, Marque P, Rischmann P.

Eur Urol. 2008 Mar;53(3):613-8. Epub 2007 Aug 28.

PMID:
17804150
19.
20.

Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients.

Mascarenhas F, Cocuzza M, Gomes CM, Leão N.

Neurourol Urodyn. 2008;27(4):311-4.

PMID:
17914742
Items per page

Supplemental Content

Write to the Help Desk